JACQUELYNN HAYS: Open Payments
NPI 1235751215 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,414 in 66 payments from 17 companies in 2025. Trend: 2023 $1,428 · 2024 $1,594 · 2025 $1,414
Food & beverage: $1,414
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $286 |
| ABBVIE INC. | 12 | $245 |
| UCB, Inc. | 10 | $189 |
| Novocure Inc. | 1 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| Eisai Inc. | 3 | $57 |
| Legend Biotech USA Inc. | 2 | $41 |
Products named: Bimzelx, Optune Lua (NovoTTF-200T), CARVYKTI, EPKINLY, DARZALEX, KEYTRUDA, SKYRIZI, TREMFYA.
Industry payments across MO — which companies pay providers there.
